Healthcare industry groups warn final 'public charge' rule could impact immigrant health, drive up costs 

An immigration board line
The Trump administration Monday finalized its “public charge” rule on immigration, and healthcare experts are warning about the negative impacts. (Getty/Tony Studio)

The Trump administration Monday finalized its “public charge” rule on immigration, and experts within the healthcare industry are warning about the potential negative impacts the regulation could have. 

Under the final rule (PDF), the Department of Homeland Security (DHS) could more easily reject green card or visa applications from people the agency deems likely to use public assistance programs such as Medicaid in the future. 

When the plan was proposed, healthcare experts warned that it could have a “chilling effect” on immigrant enrollment in these programs and could lead immigrant communities to avoid healthcare altogether. 

Free Daily Newsletter

Like this story? Subscribe to FierceHealthcare!

The healthcare sector remains in flux as policy, regulation, technology and trends shape the market. FierceHealthcare subscribers rely on our suite of newsletters as their must-read source for the latest news, analysis and data impacting their world. Sign up today to get healthcare news and updates delivered to your inbox and read on the go.

RELATED: In the middle of an immigration debate, healthcare organizations face real-world impact 

Julie Linton, M.D., a pediatrician and a member of the American Academy of Pediatrics’ Council on Immigrant Child and Family Health, said on a call with reporters Monday that the industry is already seeing some of those effects. The rule received more than 260,000 comments, including from health industry experts. 

“It is clear that the outcry from pediatricians and child health experts was ignored,” Linton said. 

Research indicates that under these provisions, many immigrants could drop out of federal health programs. The Kaiser Family Foundation projects that between 2 million and 5 million people will leave Medicaid or Children’s Health Insurance Program enrollment in the wake of the changes. 

Georgetown University researchers also noted an increase in the uninsured rate among children late last year and attributed that trend at least in part to the national rhetoric on immigration

In a statement, Rick Pollack, president of the American Hospital Association, called on DHS to “immediately reconsider this misguided and harmful rule.” 

“This rule is a step in the wrong direction when it comes to fairness with regard to the treatment of legal immigrants seeking a pathway to citizenship,” Pollack said. “And, it creates barriers to appropriately care for the sick and injured, and to keep people healthy.” 

RELATED: AHIP says public charge rule will have ‘serious negative consequences’ 

Linton said the rule’s restrictions would force some immigrants to choose—or fear they must choose—between seeking needed healthcare or keeping their families together. 

The healthcare industry could feel the rule’s impacts in finance, too. Margaret Murray, CEO of the Association for Community Affiliated Plans, said the “ill-considered” rule could have outsized impacts on safety-net providers that treat high volumes of Medicaid patients. 

“The increase in the uninsured would lead it to safety-net providers—community health centers, public hospitals, county health departments and others—to clean up the mess by forcing them to provide uncompensated care when the uninsured get sick,” Murray said. 

Bruce Siegel, M.D., president of America’s Essential Hospitals, echoed the sentiment, saying the rule threatens the “sustainability of essential hospitals” and would drive up costs for taxpayers and the system. 

Suggested Articles

The government just sweetened the pot for doctors working in underserved communities with $319 million for loan repayment and scholarship programs.

To reduce readmissions and create greater operational and cost efficiencies for providers and payers, we must rethink how we deliver and manage care.

Outpatient specialty drugs can be a lucrative income source for not-for-profit hospitals, but Washington presents some risks, Moody's says.